|
|
65. Chien Liu, op. cit., p. 275.
|
|
|
66. C. H. Stuart-Harris, G. C. Schild, op. cit., p. 203.
|
|
|
67. Ibid., p. 164.
|
|
|
68. Ibid., p. 150.
|
|
|
69. J. Salk and D. Salk, "Control of Influenza and Poliomyelitis With Killed Virus Vaccines," Science, Vol. 195, 4 March 1977, p. 842.
|
|
|
70. J. W. F. Smith. "Vaccination Strategy," in P. Selby, op. cit., pp. 277-78.
|
|
|
71. Ibid., p. 278.
|
|
|
72. C. H. Stuart-Harris, G. C. Schild, op. cit., pp. 185-193.
|
|
|
73. D. A. J. Tyrrell, "Inactivated Whole Virus Vaccine," in p. Selby, op. cit., pp. 137-140.
|
|
|
74. E. D. Kilbourne, "Future Influenza Vaccines and the Use of Genetic Recombinants," Bulletin of the World Health Organization, Vol. 41, 1969, p.643.
|
|
|
75. H. B. Dull and W. R. Dowdle, "Influenza," in P. E. Sartwell (editor), Marcy-Roseman's Preventive Medicine and Public Health, 10 ed., Appleton-Century-Crofts, New York, 1973, p. 74.
|
|
|
76. W. I. B. Beveridge, op. cit., p. 95.
|
|
|
77. J. W. G. Smith, "Vaccination Strategy," in P. Selby, op. cit., p. 280. ,
|
|
|
78. C. H. Stuart-Harris, G. C. Schild, op. cit., pp. 148-159.
|
|
|
79. H. B. Dull and W. R. Dowdle, "Influenza," in P. F. Sartwell, op. cit., p. 72.
|
|
|
80. C. H. Stuart-Harris, G. C. Schild, op. cit., 175-6.
|
